首页> 外文OA文献 >Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

【2h】

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

机译：在转移性结直肠癌的一线化疗中加入贝伐单抗的益处之大：随机临床试验的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Loupakis, Fotios; Bria, Emilio; Vaccaro, Vanja; Cuppone, Federica; Milella, Michele; Carlini, Paolo; Cremolini, Chiara; Salvatore, Lisa; Falcone, Alfredo; Muti, Paola; Sperduti, Isabella; Giannarelli, Diana; Cognetti, Francesco;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials [J] . Fotios Loupakis, Emilio Bria, Vanja Vaccaro, Journal of experimental & clinical cancer research : . 2010,第1期

机译：在转移性结直肠癌的一线化疗中加入贝伐单抗的益处：随机临床试验的荟萃分析
2. 6051 Balancing pros and cons of the addition of Bevacizumab (BEVA) to first-line chemotherapy (CT) for advanced/metastatic colorectal cancer (MCRC): Meta-analysis of randomized clinical trials exploring absolute benefits [J] . F.Cuppone, V.Vaccaro, F.Loupakis, European Journal of Cancer Supplements . 2009,第2期

机译：6051在晚期/转移性结直肠癌（MCRC）一线化疗（CT）中添加贝伐单抗（BEVA）的优缺点：探索绝对获益的随机临床试验的荟萃分析
3. Analysis of Clinical End Points of Randomised Trials Including Bevacizumab and Chemotherapy versus Chemotherapy as First-line Treatment of Metastatic Colorectal Cancer [J] . Colloca G., Venturino A., Guarneri D. Clinical oncology . 2016,第10期

机译：贝伐单抗和化学治疗与化学治疗作为转移性结直肠癌一线治疗的随机试验临床终点分析
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials [O] . Fotios Loupakis, Emilio Bria, Vanja Vaccaro, 2010

机译：在转移性结直肠癌的一线化疗中加入贝伐单抗的益处之大：随机临床试验的荟萃分析
7. Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials [O] . Fotios Loupakis, Emilio Bria, Vanja Vaccaro, 2010

机译：在转移性结直肠癌的一线化疗中加入贝伐单抗的益处之大：随机临床试验的荟萃分析

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

著录项

引文网络

相似文献

相关主题

期刊订阅